
Richard Voit
@RichardVoit
Followers
313
Following
319
Media
25
Statuses
207
Pediatric hematology/oncology | Stem cell biology | AML | Gene therapy | CRISPR
UT Southwestern
Joined December 2021
Gene therapy is transforming how we treat genetic disorders, but what if mutations in more than 30 genes can cause similar symptoms?. Now published in @CellStemCell (, we report the development of a universal gene therapy for Diamond Blackfan anemia. 1/n.
8
22
79
RT @ADiaz_PhD: Inspiring piece in @NatureCancer, "An unexpected career in cancer metabolism," highlights Dr. Ralph DeBerardinis & the pi….
0
11
0
RT @ElizSMcKenna: Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors….
0
4
0
RT @ElizSMcKenna: KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in NUP98-Rearranged….
0
3
0
RT @Elvin_Wag: Be part of the Wagenblast Lab! We are hiring a Lab Manager for leukemia & blood stem cell research at @IcahnMountSinai in NY….
0
9
0
Congratulations @michaelpoeschla and @bloodgenes. Incredible work!.
Delighted to have our work on Polygenic Modifiers of #TelomereBiologyDisorders, led by @michaelpoeschla, along with @SashaGusevPosts, @mitchiela, @SharonSavageMD, @hemanth_tummala, and others, published as an advanced online paper in @jclinicalinvest today:
1
0
2
RT @iannisaifantis1: Excited to share with all our latest work on the use of single cell tools in following IDH mutant AML patients during….
0
57
0
Kids like KK motivate everything we do in the lab @utswcancer @CRI_UTSW @UTSW_PedsHemOnc. We are now hiring so if you are looking for the next step in your scientific journey or want to learn more about what we do, please reach out.
0
0
3
We at are grateful to @TexasCCF for supporting our work. Thank you also to @dallascowboys @dak, @Jalen8Tolbert, @tonyromo, @TroyAikman for using their platform to raise awareness and funds for pediatric cancer research.
1
4
10
Congratulations Elvin and team. This is a really elegant way to probe an important clinical question underlying aggressive AMLs.
Thrilled to share the first pre-print from our lab! We tackled a big question: Why are some pediatric leukemias extremely aggressive? We explored the developmental origins of fusion-driven acute myeloid leukemia (AML). Let's dive in! #AML #NUP98 n/13
0
1
8
RT @bloodgenes: Delighted to have our Perturb-multiome paper, led by @jmartinrufino and #AlexisCaulier from our lab, published today in @Sc….
0
87
0
RT @DanaFarberNews: Congratulations to @DanaFarber’s Lara Wahlster, MD, PhD, and Nina Weichert-Leahey, MD, for receiving the American Socie….
0
5
0
RT @bloodgenes: Incredibly proud of @tGaoTeng from our lab, who is a recipient of the @HHMINEWS-@DamonRunyon fellowship!!! Congratulations,….
0
4
0
RT @CalebLareau: I am so excited to be selected as one of the recipients of the Michelson Prize from the Michelson Medical Research Foundat….
0
13
0
RT @DanaFarberNews: Congratulations @LWahlster of @DanaFarber who has been named a 2025 Damon Runyon-St. Jude Pediatric Cancer Research Fe….
0
4
0
RT @CellStemCell: Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cells
0
16
0
RT @UTSWMedCenter: Andrew Koh, M.D., @utswpediatrics and @childrens expert, discusses cutting-edge gene therapy treatments for beta thalass….
0
4
0
RT @Gerta_Hoxhaj: Excited to share our new work @ScienceAdvances in collaboration with the Labesse lab. We report the high-resolution Cryo-….
0
26
0
RT @bloodgenes: I am incredibly fortunate to be able to work with this amazing group @hhmi, @BostonChildrens, @DanaFarber, @harvardmed, @br….
0
1
0